Otofonix Encore vs Sontro Soundwave

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.

The Sontro Soundwave is a mid-priced OTC hearing aid that earns a B grade with a SoundScore of 3.0/5 in our lab testing. At $849, this behind-the-ear device uses disposable batteries and sits in the lower tier of OTC performance, ranking #61 of 65 devices in its category. The Soundwave's strongest attribute is own-voice comfort, scoring 3.6/5—a solid result that sits 1.09 points above the OTC category average. This makes it relatively comfortable for wearers who are sensitive to hearing their own voice sound unnatural or boomy. However, other performance areas present significant limitations. Speech clarity scores are below average in both quiet and noisy environments. Speech in quiet scores 2.7/5 (0.12 points below average), while speech in noise drops to 1.2/5 (0.28 points below average). Feedback handling is a notable weakness at 2.5/5, falling 2.04 points below the category average of 4.54/5. Perhaps most limiting is the music streaming score of 0.0/5, indicating this device does not support phone audio streaming—a feature many competitors in this price range offer. Consumers prioritizing own-voice comfort on a moderate budget may find the Soundwave acceptable, but those seeking strong speech clarity or streaming capability should consider alternatives. Several higher-performing OTC devices are available at similar or lower price points, including options like the Lexie Lumen or HearingAssist Control that deliver comparable or better overall sound quality.